Regulatory T cells (Treg) are supportive to cancer development in most tissues, but their role in colitisassociated colon cancer (CAC) remains unclear. In this study, we investigated the role of CD4

<p>PDF file - 43K, Supplemental Table 1. Characteristics of colon cancer patients included in the study. Supplemental Table 2. Primers.</p>

<p>PDF file - 204K</p>

<p>PDF file - 149K, Suppl. Figure 1. The induction of colitis-associated colon cancer alters the expression of GARP, CD103 and CTLA-4 on T cells and regulatory T cells. Suppl. Figure 2. Increased percentages of regulatory T cells in the peripheral blood of patients with colon cancer. Suppl. Figure 3. Impact of DT treatment on the distribution of Tregs and adaptive immunity in DEREG mice. Suppl. Figure 4. Impact of DT treatment on the distribution of Tregs in DEREG mice.</p>

<p>PDF file - 43K, Supplemental Table 1. Characteristics of colon cancer patients included in the study. Supplemental Table 2. Primers.</p>